NCT04186286 - Crossover Study of Propranolol vs Ivabradine in POTS | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Postural Tachycardia Syndrome

Interventions

DRUG

Ivabradine 4-week course

After a baseline screening assessment following a washout period of 7 days, participants will be randomized to start with a 4-week course of ivabradine.

DRUG

Propranolol 4-week course

After a baseline screening assessment following a washout period of 7 days, participants will be randomized to start with a 4-week course of propranolol.

DRUG

Placebo 4-week course

After a baseline screening assessment following a washout period of 7 days, participants will be randomized to start with a 4-week course of placebo

Trial Locations (1)

T2N 1N4

RECRUITING

University of Calgary, Calgary